Fny Investment Advisers, LLC Astrazeneca PLC Transaction History

Fny Investment Advisers, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$64.85 - $71.7 $1.61 Million - $1.78 Million	24,800 New	24,800 $1.68 Million
Q3 2022 Oct 19, 2022	BUY	$53.02 - $135.75 $3.08 Million - $7.88 Million	58,034 New	58,034 $3.18 Million
Q4 2021 Jan 10, 2022	SELL	$54.02 - $63.83 $1.92 Million - $2.27 Million	-35,610 Reduced 85.58%	6,000 $349,000
Q3 2021 Oct 13, 2021	BUY	$55.56 - $60.79 $2.31 Million - $2.53 Million	41,610 New	41,610 $2.5 Million
Q2 2021 Jul 14, 2021	SELL	$48.42 - $60.18 $2.37 Million - $2.95 Million	-48,960 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$47.16 - $54.44 $5.3 Million - $6.12 Million	-112,428 Reduced 69.66%	48,960 $2.43 Million
Q4 2020 Jan 19, 2021	BUY	$48.52 - $58.02 $7.25 Million - $8.67 Million	149,508 Added 1258.48%	161,388 $8.07 Million
Q3 2020 Oct 09, 2020	BUY	$53.07 - $61.1 $630,471 - $725,868	11,880 New	11,880 $651,000
Q2 2020 Jul 10, 2020	SELL	$43.1 - $55.31 $43 - $55	-1 Closed	0 $0
Q1 2020 Apr 09, 2020	SELL	$37.79 - $51.33 $944,674 - $1.28 Million	-24,998 Reduced 100.0%	1 $0
Q4 2019 Jan 10, 2020	BUY	$42.46 - $50.46 $1.06 Million - $1.26 Million	24,999 New	24,999 $1.25 Million
Q3 2018 Oct 29, 2018	SELL	$34.76 - $39.72 $173,800 - $198,600	-5,000 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$34.55 - $37.05 $172,750 - $185,250	5,000 New	5,000 $175,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.